Under a blazing sun, two Cameroonian health workers, Irene and Lucienne, try to convince passers-by to be vaccinated against Covid. They accost a young man in his thirties, who refuses to accept.

“I don’t trust the vaccine,” Ramos says at the outset. “White people don’t like us. They want to kill us with vaccines in which they introduce illicit products,” he says.

In Cameroon, one of the sub-Saharan African countries most affected by Covid-19 with more than 107,000 infections, including 1,795 deaths, preconceived ideas, and misinformation on social networks are holding back the vaccination campaign.

Only 4.1% of the population aged over 18 has been vaccinated since the first doses were administered seven months ago, according to the Ministry of Health, a long way from the stated objective of 40%, five weeks before the African Cup of Nations scheduled to take place in the country.

“Psychosis”

Faced with the reluctance of Cameroonians, the government has launched a double vaccination campaign: one of 5 days, from November 17 to 21, targeting the entire population, and another of one month, from November 10 to December 10, for civil servants.

Irene and Lucienne positioned themselves in the early hours of the day in front of a small public hospital in Odza, a neighborhood of Yaoundé, where a vaccination post had been opened.

Their deployment, in the middle of the street, on a busy road leading to the airport, aims to arouse the interest of passers-by. But, says Lucienne, “very few” accept the proposal. “It is very difficult to convince. There is a real psychosis among Cameroonians,” she admits.

The day before, she reports, “someone threatened to punch me if I persisted in offering him the vaccine.

The argument that comes up the most is that the “Europeans” (referring more generally to Westerners, editor’s note) want to kill us,” adds Irene, her colleague.

The two young women try to convince another passer-by, Jamiro. She also declines the offer to be vaccinated.

“I read on the internet, and also learned in the street, that this vaccine makes you sterile”, she worries.

Disinformation

“The reluctance of the population is the result of disinformation through social networks,” David Messy, an agent of the Expanded Program on Immunization (EPI, a government initiative), explained to AFP.

“Some Cameroonians in the diaspora send messages to those in the country to present the supposed harm of this vaccination,” he accuses, while “vaccination protects”.

“The government strongly and firmly encourages all populations to be vaccinated,” pleads Manaouda Malachie, Minister of Health, on CRTV, the state radio. “We have enough doses for everyone,” he said.

But authorities need to do more to convince. “The biggest challenge is getting the right information to the people, who need to make their choice based on facts and not just opinions drawn from social networks,” says Professor Yap Boum II, regional representative of Epicentre, the research and epidemiology arm of Médecins sans Frontières (MSF).

“There are 30 times fewer deaths among vaccinated people than among unvaccinated people,” he continues.

“We have to go and vaccinate Paul Biya,” says an old man in the street who is offered the vaccine. Unlike other countries where heads of state have been publicly vaccinated, in Cameroon it is not known whether Mr. Biya, 88 years old, 39 of them in power, is vaccinated or not.

His Prime Minister, Joseph Dion Ngute, and some of his ministers have taken their shots on camera.

But some Cameroonians still question the existence of the virus, deeming the vaccine useless. “I’m not interested in the vaccine because I haven’t seen anyone sick yet. I doubt the existence of this disease,” says Jeannette Aboudi, 53, an orange seller in the market of Nfou, a small town in central Cameroon.

Andréa, a young woman in her twenties, has no hesitation since her aunt contracted respiratory distress from the virus. “After that, the family decided that everyone should be vaccinated,” she says, adding that she recently took her first dose.

Source: AFP

In the book ‘The Congo Cables: From Eisenhower to Kennedy,” there is a detailed plan in the presence of a sitting US president to assassinate Patrice Lumumba, whom the US considered a threat to its national interests. Nothing has changed since that plot to assassinate that great pan-Africanist about how the US and western nations operate internationally. It is all about national interests and the concerns of big western businesses. Many governments have figured out how to function internationally, but sub-Saharan African countries have not.”

If any evidence is required that Africa is considered on the global stage as only suitable for supplying vital raw materials for the rest of the world, the COVID-19 pandemic has made that clear. The UK, EU, and the USA’s latest travel bans on travelers from nine African countries have come as no surprise. The ban comes as the Centre for Disease Control announced that no cases of the Omicron virus had been found in the US. Why then was a ban against scientific advice imposed on these nine African countries?

Politics in the international arena have been laid bare since the coronavirus pandemic started.  Ever since the Covid-19 vaccine was manufactured over twelve months ago, the rich countries of the West have gone into hoarding and isolationist mode. Internationalism has had to wait as the rich countries look after their citizens and big businesses first, while hundreds of thousands die in Africa, Asia, and South America.

Although governments paid for many Covid-19 vaccine researches, the subsequent vaccine and cures have become the property of the world’s biggest pharmaceutical businesses. And they are waxing fat from the profits and patents. Due to the urgency of the moment and the havoc this global virus is causing worldwide, South Africa and India have led calls for rich nations to suspend intellectual property agreement that allows pharmaceutical conglomerates to monopolize medical knowledge. This proposal, expected to save millions of lives in developing countries, has been blocked by the UK and the EU. This is shameful.

The Omicron virus is the result of vaccine-nationalism, vaccine-apartheid, vaccine hoarding and a neo-colonial mindset. Scientists now say if immediate action is not taken to vaccinate the populations of the developing countries; more variants will make their appearance soon. Western nations have snatched and keep accumulating as many million vaccine doses as they can and are accomplishing some of the highest vaccination rates in the world. According to COVAX, around 100m of the vaccines in Western countries will pass their use-by dates in December while people in developing countries are dying from a global pandemic that was not their creation.

The disparity in vaccination numbers around the globe makes for depressing reading. South Africa has achieved only 27% vaccination rate, while most Western countries have attained vaccination rates higher than 69% with vaccines produced by Johnson & Johnson in South Africa. The vaccination rates in other parts of Africa are lamentable. According to the live tracker at https://africanarguments.org/, Chad has vaccinated 250,000 of its 16.5 million people. Cameroon has vaccinated 924,000 of its 26 million people. Nigeria has vaccinated 10.5 million of its 205 million inhabitants. The numbers are pathetic, but this is not a western problem; this is our—African—problem. The time for a change in Africa is now.

The international community has failed Africa if it cannot put lives before profits in a global pandemic. Our leaders and continent cannot afford to rely on cooperation with a world that values us not. We are better than just supplying raw materials and young qualified professionals to oil the economic wheels of the West. The time has come for Africans to realize that the world order and global institutions created after 1945 have failed our continent.

It is an open secret that African leaders have been nothing short of embarrassments for the last forty years, and their people, at home and in the diaspora, have been rightfully disappointed with them. Africa has had its fair share of self-inflicted injury, from auctioning its raw materials to western companies for private gain for the political elite to butchering constitutions to stay in power forever; our recent past has been unpleasant.

This global pandemic has presented an opportunity for many African leaders to rehabilitate themselves with their people. Many Africans are now prepared to give their leaders another chance. African leaders must start putting African structures and institutions in place to serve their people. China has shown that you can lift 600 million people from extreme poverty within a generation. Africa has 1.3 billion people, and many are young, educated, and hungry for success. We have trillions of dollars worth of raw materials scattered around the continent. No continent is blessed with more natural materials and people potential than Africa.

How can vaccines manufactured cheaply in Africa be cheaper in Europe and the US than in Botswana? This is where political leadership comes in. Presidents Kagame, Nana Akufo-Addo and Ramaphosa must assume leadership immediately and invite African philanthropists, scientists, academics and billionaires to fashion concrete plans on how our continent should shield itself from future pandemics and shocks. This is the first step towards restoring self-pride.

For many in Africa, the lesson from this pandemic is painful as African governments have found it hard to protect their citizens. In contrast, the West has displayed its ruthlessness and selfishness. They might not plot to poison another Lumumba, but Western ways have not changed. It is called self-interest.  After this pandemic, it cannot be business as usual. We must seize the moment and build institutions that work for Africa.

By Isong Asu

Cameroon Concord News

Senior Political Researcher in London

At least eight people have died and more than 180 others infected in a cholera epidemic that is sweeping across two health districts in Southwest region, international medical charity Doctors Without Borders (MSF) said on Tuesday.

“The Ekondo Titi Health District has reported over 160 cases of cholera, with 62 patients hospitalized at the Cholera Treatment Unit, 15 patients treated at the Oral Rehydration points, and 5 deaths recorded. The Bakassi Health district has also reported 29 suspected cases with three deaths from October 27 to November 29. The condition is particularly worrying because it means that cholera has spread in the community,” Donatien Tshishimbi, MSF Medical Coordinator said in a statement released by MSF on Tuesday.

The population is vulnerable to infectious diseases like cholera because access to health care is difficult and the living conditions are poor, MSF said.

The international medical charity has established two cholera treatment centers and dispatched a team of health personnel to the affected areas to provide free treatment to the population.

In early November, the country’s health authorities in the region warned that cholera was spreading in parts of the region accompanied by a rise in COVID-19 cases.

Cholera, which is spread by ingesting fecal matter, causes acute watery diarrhea and can kill within hours if not treated.

Source: Xinhuanet

Covid vaccines began to show promise just months after the novel coronavirus started spreading across the globe. So why have decades of HIV/AIDS research yielded so little progress on a jab to prevent a disease that claimed some 680,000 lives in 2020?

As the globe marks World AIDS Day on Wednesday, why is there still no vaccine to protect people from the Human Immunodeficiency Virus (HIV)?

One answer is that the political will and colossal investment that have spurred on Covid vaccine development have largely been missing from AIDS vaccine research since HIV was discovered in 1983.

But another lies in the complexity of the science behind HIV.

“With Covid vaccines, researchers worry about the vaccine being able to fend off a handful of variants that have become particularly worrisome,” reads a June report by the International AIDS Vaccine Initiative (IAVI).

“But for HIV, there are millions and millions of different viruses that have resulted from the virus’s stealth ability to rapidly mutate… It is this astonishing level of diversity that any HIV vaccine must contend with.”

Olivier Schwartz, head of the viruses and immunity unit at the Pasteur Institute in Paris, says that while most people can recover naturally from an initial coronavirus infection and thus acquire immunity, this is not the case for HIV.

“HIV mutates much more easily than Covid and so it is more difficult to generate so-called broadly neutralising antibodies that could prevent infection,” he said.

Only a handful of people naturally produce these antibodies when exposed to HIV.

Research into a vaccine has meant studying those rare responses, understanding how they work, and trying to replicate them in healthy people’s immune systems.

An mRNA jab?

Several dozen vaccines are being studied, with one by US firm Moderna seeking to use the same mRNA delivery method as its popular Covid vaccine.

The June report describing the research explains how the mRNA jab is meant to deliver instructions for a process called “germline targeting”.

This means “guiding the immune system, step by step, to induce antibodies that can counteract HIV”, the report explains.

So far, the technique is complex, involving an initial shot to activate important B-cells before several jabs attempt to spur the body into producing a range of antibodies.

Being able to visualise a way forward has given researchers hope, and some say it’s thanks in no small part to the pandemic.

“These last few years have seen unprecedented growth in our understanding of the immune system,” Serawit Bruck-Landais of French AIDS organisation Sidaction told AFP.

But even with seeming breakthroughs, Bruck-Landais says, progress on an HIV jab is “not enough to be able to say we will have an AIDS vaccine soon”.

The US clinical trials for the Moderna vaccine that were set to begin in August are still listed on the National Institutes of Health website as “not recruiting”.

‘Lack of investment’

Researchers looking into vaccines say they are overlooked in terms of funding.

“The market is too weak for pharmaceutical groups and there’s a disappointing lack of investment,” says Nicolas Manel, a research director at the French National Institute of Health and Medical Research (INSERM).

“Many researchers are very motivated, but they have to make do with the funds they have.”

In the absence of a vaccine, focus has historically been on promoting preventative measures like protected sex, clean needles, and overall better access to healthcare for marginalised populations.

Some 38 million people across the globe live with the virus.

Monsef Benkirane, research director at the France-based Institute of Human Genetics, points to important improvements in medicine that allow many people with HIV to live longer, healthier lives.

Importantly, by reducing an infected person’s viral load, HIV treatments today can vastly decrease or eliminate a person’s chances of transmitting HIV to another person.

But Benkirane says many people lack access to the treatments, while those who do have access sometimes struggle to follow through and take all the necessary medications.

“In addition to improving access to treatments, there are still problems with people actually sticking to the treatment regimens, even in Europe,” he said.

Source: AFP

The Dutch government on Friday ordered further restrictions including a nighttime closure of bars, restaurants and most stores to stem a record-breaking wave of COVID-19 cases that is threatening to overwhelm the country’s healthcare system.

The surge in the Netherlands, the worst in Western Europe, came even though 85% of the adult population have been vaccinated, with infections now rising most quickly among schoolchildren, who are not vaccinated.

“The (infection) numbers per day are high, higher, highest,” caretaker Prime Minister Mark Rutte said at a televised press conference. “That means that we can’t get there with just a few small adjustments.”

The current wave of Dutch cases, running above 20,000 infections per day for the past week, has continued despite restrictions including the reintroduction of face masks and closure of bars and restaurants after 8 p.m. imposed by Rutte’s government earlier this month.

Rutte said on Friday non-essential stores would be closed from 5 p.m. to 5 a.m., and masks would be required in secondary schools.

His government urged everyone who can to work from home, and if they cannot, to follow social distancing guidelines.

The new measures go into effect from Nov. 28.

Some experts had argued that a short, near-total lockdown, including school closures, would be needed to push infections down.

Law enforcement officials were preparing for possible unrest after a demonstration in The Hague on Friday to protest against the new measures.

A government proposal – which is not yet policy – to bar unvaccinated people from public places prompted three nights of rioting last weekend.

Dutch hospitals were instructed on Friday to postpone all non-emergency operations to free up beds in intensive care units. Some patients have been transferred to neighbouring Germany.

Source: REUTERS

Europe remains “in the firm grip” of COVID and the death toll on the continent could top 2.2 million this winter if current trends continue, the World Health Organization said Tuesday.

Some 700,000 could die in the coming months, the WHO said, as cases creep up across Europe, prompting some countries to reimpose tough restrictions.

The WHO expects “high or extreme stress in intensive care units (ICUs) in 49 out of 53 countries between now and March 1, 2022”.

“Cumulative reported deaths are projected to reach over 2.2 million by spring next year,” it added, up from the current 1.5 million.

COVID-19 is the leading cause of death across Europe and Central Asia, the WHO reported, citing figures from the Institute for Health Metrics and Evaluation.

The rise in Europe was being driven by a combination of the highly-contagious Delta variant, insufficient vaccination coverage and the easing of measures such as mask wearing and physical distancing, it said.

According to WHO data, COVID-related deaths increased last week to nearly 4,200 a day, doubling from 2,100 deaths a day at the end of September.

The WHO also said evidence was growing that vaccine-induced protection against infection and mild disease was declining.

“The COVID-19 situation across Europe and Central Asia is very serious. We face a challenging winter ahead,” regional director for WHO Europe, Hans Kluge, said in a statement.

He called for a “vaccine plus” approach, consisting of vaccinations, social distancing, the use of face masks and hand washing.

The WHO said face masks reduce COVID incidence by 53 percent according to a recent study, and “over 160,000 deaths could be prevented (by March 1) if universal mask coverage of 95 percent was achieved”.

(Source: AFP)

Kenyans will have to prove they are fully vaccinated against Covid-19 to gain access to government services and public places such as national parks, bars and restaurants under new health regulations.

The move comes despite Kenya recording a declining number of coronavirus infections in recent weeks, but against a backdrop of heightened restrictions in some European countries that are battling soaring cases.

Kenya will require people to show vaccination certificates from December 21, and is planning a 10-day mass inoculation campaign from November 26, Health Minister Mutahi Kagwe said in a statement issued late Sunday.

Visitors from Europe will also have to provide proof of full vaccination, he added.

Kenya, Kagwe said, has seen a “marked decrease” in the number of severe cases and deaths, with a positivity rate over the last 14 days ranging from 0.8 percent to 2.6 percent.

Since the start of the pandemic, the East African powerhouse has recorded a total of 254,629 cases and 5,325 deaths.

‘Not yet time to celebrate’

“I have no doubt that looking at these statistics, it’s very easy to become complacent and fail to appreciate the magnitude of the problem that we still face with the pandemic,” Kagwe said.

“The current decline in the number of new infections may be attributed to a buildup of immunity both through natural exposure to the disease and the ongoing vaccination exercise. Nonetheless we know that it’s not yet time to celebrate.”

Only 2.4 million people, or less than nine percent of Kenya’s adult population, have been vaccinated, according to official figures, compared with a government target of 30 million by the end of next year.

Kagwe voiced concern about the low uptake of Covid shots, particularly among the elderly, and said it had slowed after the lifting of a night-time nationwide curfew last month.

He said Kenya had received a total of 10.7 million vaccine doses and expected to get another eight million, without giving a timeframe.

Under the new measures, in-person access to government services including hospitals, education, tax and immigration offices will be limited to those carrying proof of vaccination.

Similar restrictions will be imposed for public places such as national parks and game reserves, hotels, bars and restaurants, while all indoor gatherings will be limited to two-thirds capacity for vaccinated people only.

All those working in the public transport sector, such as pilots, drivers and “boda boda” motorcycle taxi drivers must also be fully inoculated.

Source: AFP

Authorities in Cameroon say fewer than 300 of a targeted 300,000 state workers have agreed to be vaccinated against COVID-19 two weeks into a campaign. Some civil servants who spoke to VOA hold a mistaken belief that the virus is no longer a threat in Cameroon. But health officials say vaccinations in the Central African state must be stepped up amid concerns about another wave of infections.

Several dozen people enter and leave Cameroon’s Public Service and Administrative Reform Ministry Thursday morning. At the ministry’s courtyard is a new stand where civil servants can get COVID-19 vaccines free of charge.

Vaccination team member Roland Njalla said only 11 of the expected 400 ministry employees have volunteered to be vaccinated over the past 10 days.

“People are not well informed and edified as to what the vaccine is going to bring as an advantage, as a plus. People are afraid, they don’t know the side effects of the vaccine. I think that is the principal problem,” he said.

Cameroon officially launched a one-month campaign to vaccinate at least half of its 600,000 active and retired government workers against COVID-19 November 10. Vaccinations started five days before the official launch.

The Public Health Ministry says it has vaccinated just 300 of the 300,000 expected active and former state workers.

Public Service and Administrative Reform Minister Joseph Le said he is pleading with workers to accept the COVID-19 vaccine.

“This campaign is intended to ensure that the professional environment is not a place where the virus spreads, but a suitable environment for professional development for all of us. We will continue to emphasize that vaccination is the only way to protect ourselves from the devastating effects of this terrible pandemic,” he said.

Cameroon announced last month that the COVID-19 Delta variant was present in the country and infection rates were increasing.

The health ministry is encouraging people to be vaccinated and continue to wear face masks, wash their hands regularly and keep at least a meter from each other.

Health Minister Manaouda Malachie said people are reluctant to take the vaccine because of lack of awareness, rumors and exposure to misinformation spread mainly on social networks.

Manaouda said 1993 Nobel Peace Prize winner Nelson Mandela, whom many Cameroonians consider their mentor, once called vaccinations the most powerful of all preventive health measures. He says the COVID-19 vaccine saves lives and reduces the risk of getting and spreading the virus.

The Cameroon Bar Association said last month that some government officials were blocking unvaccinated civilians from public offices.

Evaristus Morfaw Nkafu, president of the General Assembly of the Cameroon Bar Association, said no law compels public service users to provide vaccination cards.

“There are some authorities who have decided that those who are not inoculated will not enter into their premises. It means they are discriminating against Cameroonians. Rather than coercing, I think the government should educate the people. They should persuade the people and even give incentives,” said Nkafu.

Nkafu said a campaign to raise awareness on COVID-19 vaccination should be offered to those who are hesitant by reaching out and providing crucial information where they live.

The government denied that it is compelling people to be vaccinated.

It is definitely encouraging the jabs.Only one-half percent of the targeted 12 million people were fully vaccinated as of October 30.

Source: VOA

US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least-wealthy countries.

Pfizer will sub-licence production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent of the world’s population.

Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer — which also produces one of the most widely-used Covid vaccines with German lab BioNTech — will not receive royalties from the generic manufacturers, making the treatment cheaper.

The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.

The Pfizer drug is to be taken with the HIV medicine ritonavir.

Interim data from ongoing trials demonstrated an 89 percent reduction in the risk of Covid-19-related hospitalisation or death compared to a placebo, in non-hospitalised high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Similar results were seen within five days of symptom onset, it added.

The Geneva-based MPP is a United Nations-backed international organisation that works to facilitate the development of medicines for low- and middle-income nations.

If approved, the pill could be on the market in “a matter of months”, MPP policy chief Esteban Burrone told AFP.

Pfizer also said Tuesday  that it was seeking an emergency use authorisation, or EUA, in the US for the Covid pill.

HIV drug mix

Pfizer will forego royalties on sales in all countries covered by the agreement while Covid-19 remains classified as a Public Health Emergency of International Concern by the World Health Organization.

Last month, the WHO maintained the highest level of alert over the spread of the SARS-CoV-2 virus that causes Covid-19.

Paxlovid, or PF-07321332, is an investigational antiviral therapy designed to block the activity of the SARS-CoV-2-3CL protease — an enzyme that the coronavirus needs to replicate.

Taking it together with a low dose of ritonavir helps slow the breakdown of PF-07321332. It therefore remains active in the body for a longer period at a high concentration, to help combat the virus.

The pill could potentially help patients avoid severe illness, which can lead to hospitalisation and death, Pfizer said.

“We believe oral antiviral treatments can play a vital role in reducing the severity of Covid-19 infections, decreasing the strain on our healthcare systems and saving lives,” said Pfizer chairman and chief executive Albert Bourla.

While a multitude of vaccines have been rolled out in the pandemic, the hunt for treatments for those who have already caught the disease has not been as fruitful.

Agreement follows Merck deal

The MPP was founded by Unitaid, which works on innovations to prevent, diagnose and treat major diseases in poorer countries.

“During a pandemic, saving time means saving lives. This agreement could help us to reach more people more quickly as soon as the medicine is approved,” said Unitaid executive director Philippe Duneton.

Potential sublicensees have until December 6 to register an expression of interest.

The announcement comes after the MPP signed a similar voluntary licensing deal with Pfizer’s US rivals Merck & Co last month for its investigational oral antiviral medicine molnupiravir.

Subject to regulatory approval, the deal will help create broad access to molnupiravir in 105 low- and middle-income countries.

Pills are easier to make than vaccines, do not require a cold chain for delivery and can be self-administered by the patient.

In terms of relieving health systems by preventing hospitalisations, “it’s a game changer”, said Burrone.

He said pricing for the Pfizer pill had not yet been set, but said that “in a competitive environment… the prices tend to come down” to a low level.

Doctors Without Borders (MSF) meanwhile suggested it might cost around $700 per Pfizer treatment course, in line with molnupiravir.

The medical charity said it was disheartened by the deal, saying restrictive voluntary licences were no substitute for guaranteed global access to Covid tools to bring the pandemic under control.

Source: AFP

Hundreds of thousands of people suffer from leukemia in all parts of the world, and many ultimately lose their fight against the disease. While there is currently no cure for leukemia, it is possible to treat the cancer to prevent it from coming back.

A biochemistry researcher at the University of Yaounde Medical School in Cameroon’s capital said she developed a plant-based solution to fight leukemia.

“My solution is to make xenografts by administering an aqueous extract of plant bark powder to mice capable of developing tumors,” Francine Tankeu told Anadolu Agency (AA). “We make them leukemic beforehand and then we follow their evolution.”

The next step is to arrange the remedy in a final physical aspect of the drug as it will be used in a patient and according to its compatibility.

“This other step includes several aspects such as toxicological studies to ensure its safety before moving to the human stage (of trials),” said Tankeu.

She noted results on animals show a significant regression of tumor volume after 30 days.

“The survival rate is good, but the test has not yet been performed on a human patient. The steps to be taken before clinical testing, like human trials, are not complete and I don’t have enough funds,” she said.

The idea to use plants came from her daily life, where she noticed a majority of the population uses traditional plant-based medicine for diseases.

“The beneficial effects of Syzygium Guineense, the plant I use, are not negligible because its activity is anti-leukemic. Beyond being used as a spice for local dishes, it is also used for the treatment of certain cancers,” she said.

‘Improved traditional medicine’

She figured if she could establish a scientific basis for the traditional use and formulate an improved traditional medicine, it would be “very useful.”

The methodology is “in tune with African socio-cultural realities” she said.

Tankeu wants to formulate “an improved traditional medicine” and to study the effects of the leafy forest plant when it is administered in conjunction with anti-cancer drugs to see if there would be a synergistic effect or a reduction in side effects from chemotherapy.

She received the Young Talent Award In 2020 from the For Women in Science in Sub-Saharan Africa program at the L’Oreal Foundation and UNESCO.

This prize allowed her to realize her work is “an effective contribution to the problem of cancer,” she said.

But the fight remains “vast, long and far from being won in view of the growing number of patients in the world as well as the obstacles to scientific research,” said Tankeu.

It is “very complicated in my country” for several reasons she told the Turkish news agency.

Notably, the lack of financial avenues, absence of technical platforms and prejudice against female scientists.

She noted that teachers prefer to work with male researchers because of perceptions that family responsibilities of women present obstacles.

In addition, “many children die before they are even put on treatment because the standard of living of the inhabitants is lower than the cost of examinations for an accurate diagnosis,” she said.

The number of cancer cases is increasing annually in Cameroon and diagnosis times are long – more than 60% of patients arrive at an advanced stage and treatment is expensive – according to the Health Ministry.

Tankeu also lamented about erroneous beliefs and perceptions

“It is a real barrier,” she said.

Despite the situation, the young biochemist said she views the future of her solution with “a lot of optimism, especially given the previous results.”

Source: Daily Sabah